72.73

1.80% -1.33

Pre-market: 72.41 -0.32 -0.44%

Bright Minds Biosciences Inc (DRUG)

Overview News Price History Discussions Forecast Stock Split

Bright Minds Biosciences Inc stock is traded at $72.73, with a volume of 119.99K. It is down -1.80% in the last 24 hours and up +41.80% over the past month. Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Previous Close:

$74.06

Open:

$72.69

24h Volume:

119.99K

Relative Volume:

0.83

Market Cap:

$515.56M

Revenue:

Net Income/Loss:

$-4.98M

P/E Ratio:

-55.19

EPS:

-1.3177

Net Cash Flow:

$-3.85M

1W Performance:

+9.93%

1M Performance:

+41.80%

6M Performance:

+163.99%

1Y Performance:

+71.90%

1-Day Range:

$71.10

$74.05

1-Week Range:

$66.14

$75.99

52-Week Range:

$23.18

$75.99

Bright Minds Biosciences Inc Stock (DRUG) Company Profile

Name

Bright Minds Biosciences Inc

Sector

Healthcare (1131)

Industry

Biotechnology (632)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

DRUG's Discussions on Twitter

Compare DRUG with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DRUG Bright Minds Biosciences Inc	72.73	524.98M	0	-4.98M	-3.85M	-1.3177
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-08-25	Initiated	BTIG Research	Buy
May-13-25	Initiated	TD Cowen	Buy
May-07-25	Initiated	Chardan Capital Markets	Buy
Jan-23-25	Initiated	Piper Sandler	Overweight
Jan-10-25	Initiated	Cantor Fitzgerald	Overweight
Jan-10-25	Initiated	H.C. Wainwright	Buy
Nov-26-24	Initiated	Robert W. Baird	Outperform

View All

Bright Minds Biosciences Inc Stock (DRUG) Latest News

01:59 AM

Bright Minds Biosciences (NASDAQ:DRUG) Cut to Hold at Zacks Research - Defense World

01:59 AM

Dec 04, 2025

Why Bright Minds Biosciences Inc. stock attracts high net worth investorsPortfolio Growth Summary & Fast Gaining Stock Strategy Reports - Newser

Dec 04, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat

Dec 04, 2025

Cantor Fitzgerald Analysts Lower Earnings Estimates for DRUG - MarketBeat

Dec 04, 2025

An Intrinsic Calculation For Bright Minds Biosciences Inc. (CSE:DRUG) Suggests It's 44% Undervalued - simplywall.st

Dec 04, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Targets Neurological Disorders - Kalkine Media

Dec 04, 2025

What technical signals suggest for Bright Minds Biosciences Inc. stockJuly 2025 Patterns & Reliable Volume Spike Alerts - Newser

Dec 03, 2025

Dec 01, 2025

Cantor Fitzgerald reiterates Overweight rating on Bright Minds Biosciences stock - Investing.com Nigeria

Dec 01, 2025

Nov 29, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Reaches New 1-Year HighTime to Buy? - MarketBeat

Nov 29, 2025

How institutional buying supports Bright Minds Biosciences Inc. stockPortfolio Performance Report & High Accuracy Investment Signals - moha.gov.vn

Nov 29, 2025

Nov 28, 2025

What drives Bright Minds Biosciences Inc stock priceConsumer Goods Stocks & Free Rapid Wealth Multiplication - earlytimes.in

Nov 28, 2025

How Bright Minds Biosciences Inc. stock performs in high volatility markets2025 Year in Review & Consistent Growth Equity Picks - BỘ NỘI VỤ

Nov 28, 2025

Nov 27, 2025

Will Bright Minds Biosciences Inc. stock deliver shareholder valueMarket Trend Report & Technical Pattern Based Signals - moha.gov.vn

Nov 27, 2025

Recent Price Trend in Bright Minds Biosciences Inc. (DRUG) is Your Friend, Here's Why - sharewise.com

Nov 27, 2025

Nov 26, 2025

Brokerages Set Bright Minds Biosciences Inc. (NASDAQ:DRUG) Target Price at $81.00 - Defense World

Nov 26, 2025

Nov 25, 2025

Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting - The Manila Times

Nov 25, 2025

Bright Minds (NASDAQ: DRUG) to Present at Piper Sandler Event, 2025 AES Meeting - Stock Titan

Nov 25, 2025

Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 36.27%: Read This Before Placing a Bet - sharewise.com

Nov 25, 2025

Nov 24, 2025

FY2025 Earnings Forecast for DRUG Issued By Chardan Capital - MarketBeat

Nov 24, 2025

Nov 23, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Nov 23, 2025

Nov 22, 2025

Responsive Playbooks and the DRUG Inflection - news.stocktradersdaily.com

Nov 22, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Upgraded at Chardan Capital - Defense World

Nov 22, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Rating Increased to Strong-Buy at Chardan Capital - MarketBeat

Nov 22, 2025

Nov 21, 2025